IN FOCUS: Solvias
Pharmaceutical Technology
DECEMBER 9, 2022
Beyond our expertise in small molecules, we have built a solid reputation with biopharmaceutical companies for the characterisation and analysis of monoclonal antibodies, therapeutic proteins and biosimilars. All our equipment is in line with the latest European Medicines Agency (EMA) and FDA methods. HQ ADDRESS: Römerpark 2.
Let's personalize your content